Clinical Trial Update: Safety Study of Olesoxime in Patients With Stable Relapsing Remitting Multiple Sclerosis Treated With Interferon Beta. [Phase 1]

View source ↗

Summary

This is a completed Phase 1 safety study evaluating olesoxime in patients with Relapsing-Remitting Multiple Sclerosis who are treated with interferon beta.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Olesoxime (TRO19622)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Relapsing Remitting Multiple Sclerosis | Phase 1 | Status: COMPLETED